Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study). (Q34660081)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study).	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

based on heuristic

inferred from title

Gunnar Folprecht

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Thomas Gruenberger

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Wolf Otto Bechstein

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

H-R Raab

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

J Weitz

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

F Lordick

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

J T Hartmann

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

J Stoehlmacher-Williams

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

H Lang

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

T Liersch

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

D Ockert

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

D Jaeger

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

U Steger

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

T Suedhoff

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

A Rentsch

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

C-H Köhne

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

27 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1018-1025

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Surgical management and outcomes of colorectal cancer liver metastases

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

A systematic review of repeat hepatectomy for recurrent colorectal liver metastases.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Can chemotherapy be discontinued in unresectable metastatic colorectal cancer? The GERCOR OPTIMOX2 Study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Patients' expectations about effects of chemotherapy for advanced cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Patients' perspectives on palliative chemotherapy of colorectal and non--colorectal cancer: a prospective study in a chemotherapy- experienced population

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Prognostic models for outcome following liver resection for colorectal cancer metastases: A systematic review.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34660081&oldid=2087464894"